Annual Long Term Debt
$10.24 M
-$1.97 M-16.11%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual long term debt is $10.24 million, with the most recent change of -$1.97 million (-16.11%) on December 31, 2022.
- During the last 3 years, AMAM annual long term debt has risen by +$7.05 million (+220.86%).
Performance
AMAM Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$8.61 M
-$555.00 K-6.06%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly long term debt is $8.61 million, with the most recent change of -$555.00 thousand (-6.06%) on September 1, 2023.
Performance
AMAM Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AMAM Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.1% | - |
| 3 y3 years | +220.9% | +438.7% |
| 5 y5 years | +220.9% | - |
AMAM Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | at low | -29.5% | at low |
| 5 y | 5-year | -16.1% | -84.4% | -29.5% | -91.4% |
| alltime | all time | -16.1% | -84.4% | -29.5% | -91.4% |
Ambrx Biopharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $8.61 M(-6.1%) |
| Jun 2023 | - | $9.16 M(-5.6%) |
| Mar 2023 | - | $9.71 M(-5.2%) |
| Dec 2022 | $10.24 M(-16.1%) | $10.24 M(-8.9%) |
| Jun 2022 | - | $11.25 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $12.21 M(+664.2%) | - |
| Dec 2021 | - | $12.21 M(+1550.3%) |
| Jun 2021 | - | $740.00 K(-53.7%) |
| Dec 2020 | $1.60 M(-50.0%) | - |
| Dec 2020 | - | $1.60 M |
| Dec 2019 | $3.19 M | - |
FAQ
- What is Ambrx Biopharma annual long term debt?
- What is the all time high annual long term debt for Ambrx Biopharma?
- What is Ambrx Biopharma annual long term debt year-on-year change?
- What is Ambrx Biopharma quarterly long term debt?
- What is the all time high quarterly long term debt for Ambrx Biopharma?
What is Ambrx Biopharma annual long term debt?
The current annual long term debt of AMAM is $10.24 M
What is the all time high annual long term debt for Ambrx Biopharma?
Ambrx Biopharma all-time high annual long term debt is $12.21 M
What is Ambrx Biopharma annual long term debt year-on-year change?
Over the past year, AMAM annual long term debt has changed by -$1.97 M (-16.11%)
What is Ambrx Biopharma quarterly long term debt?
The current quarterly long term debt of AMAM is $8.61 M
What is the all time high quarterly long term debt for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly long term debt is $12.21 M